BLADE Entertainment CO.,LTD.

A044480

KR7044480002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
992 ^KRW	+0.10%		-10.39%	-12.21%

May. 21	Humasis Co. Ltd. completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd.	CI
May. 17	Humasis Co. Ltd. entered into an agreement to acquire 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd for KRW 48 billion.	CI

BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.

May 12, 2019

BioGenetics CO.,LTD. (KOSDAQ:A044480) acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion on May 13, 2019.

BioGenetics CO.,LTD. (KOSDAQ:A044480) completed the acquisition of additional unknown stake in Kyung Nam Pharm Co.,Ltd. on May 13, 2019.

Latest news about BLADE Entertainment CO.,LTD.

Humasis Co. Ltd. completed the acquisition of 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd.	May. 20	CI
Humasis Co. Ltd. entered into an agreement to acquire 34.80% stake in BLADE Entertainment CO.,LTD. from Metaplex Co., Ltd. and Flake Co., Ltd for KRW 48 billion.	May. 16	CI
BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding	23-07-03	CI
Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4%	23-06-21	MT
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in funding	23-06-20	CI
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 10 billion in funding	23-01-05	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.	21-12-23	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6 billion in funding	21-12-09	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6 billion in funding	21-11-29	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 5 billion in funding from Metaplex Co., Ltd.	21-11-28	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 5 billion in funding from Metaplex Co., Ltd.	21-11-23	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6.999999435 billion in funding from Jang San Co.,Ltd.	21-11-08	CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6.999999435 billion in funding from Jang San Co.,Ltd.	21-09-23	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-19	CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.	21-07-11	CI
Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd.	21-04-14	CI
Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd.	21-03-09	CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.	20-06-30	CI
Livefinancial Co.,Ltd. acquired additional 5.8% stake in KyungNam Biopharma CO.,LTD. from Widwin Investment Co., Ltd. for KRW 4 billion.	20-06-03	CI
ESV Inc. announced that it has received KRW 4.999999932 billion in funding from KyungNam Biopharma CO.,LTD.	20-05-31	CI
KyungNam Biopharma CO.,LTD. announced that it has received KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd.	20-04-02	CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.	20-03-29	CI
BioGenetics CO.,LTD. announced that it expects to receive KRW 1.499998005 billion in funding from Livefinancial Co.,Ltd.	20-03-25	CI
CODI-M Co., LTD. announced that it has received KRW 1.999999944 billion in funding from BioGenetics CO.,LTD.	20-03-17	CI
ESV Inc. announced that it expects to receive KRW 4.999999932 billion in funding	20-02-26	CI

Chart BLADE Entertainment CO.,LTD.

Duration

Period

More charts

Company Profile

Blade Entertainment Co Ltd, formerly Blueberry NFT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the manufacture and sale of medicines such as vitamins, placentas and health foods. The Company is also engaged in the manufacture and sale of rubber products such as condoms and gloves, as well as masks such as KF-94. In addition, the Company is engaged in the development and provision of software such as non-fungible tokens (NFTs).

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BLADE ENTERTAINMENT CO.,LTD.	-12.21%	28.43M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.91%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.40%	22.34B
SANDOZ GROUP AG	+18.48%	15.25B
CIPLA LIMITED	+16.12%	14B
ZYDUS LIFESCIENCES LIMITED	+45.12%	12.06B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-9.58%	6.8B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B